Colorado § 25-4-2002 Legislative declaration

Colorado Statutes

§ 25-4-2002 — Legislative declaration

Colorado § 25-4-2002

Title 25Public

Art.Disease Control

This text of Colorado § 25-4-2002 (Legislative declaration) is published on Counsel Stack Legal Research, covering Colorado primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Colo. Rev. Stat. § 25-4-2002 (2026).

Text

(1)The general assembly hereby finds, determines, and declares that:

(a)Hepatitis C is a silent killer, being largely asymptomatic until irreversible liver damage may have occurred;

(b)Hepatitis C has been characterized by the world health organization as a disease of primary concern to humanity;

(c)Currently, approximately four million five hundred thousand Americans are infected with hepatitis C, and there are approximately thirty thousand new infections occurring each year in the United States;

(d)The center for disease control estimates that approximately twelve thousand individuals die each year due to the consequences of hepatitis C, and this number continues to grow each year;

(e)Hepatitis C is considered such a public health threat that the United States departme

Free access — add to your briefcase to read the full text and ask questions with AI

(1) The general assembly hereby finds,
determines, and declares that:

(a) Hepatitis C is a silent killer, being largely asymptomatic until irreversible
liver damage may have occurred;

(b) Hepatitis C has been characterized by the world health organization as a
disease of primary concern to humanity;

(c) Currently, approximately four million five hundred thousand Americans
are infected with hepatitis C, and there are approximately thirty thousand new
infections occurring each year in the United States;

(d) The center for disease control estimates that approximately twelve
thousand individuals die each year due to the consequences of hepatitis C, and this
number continues to grow each year;

(e) Hepatitis C is considered such a public health threat that the United
States department of health and human services has launched a comprehensive
plan to address it, beginning with the identification and notification of the hundreds
of thousands of persons inadvertently exposed to hepatitis C through blood
transfusion; and

(f) In the absence of a vaccine for hepatitis C, emphasis must be placed on
other means of disease awareness and prevention, including but not limited to
education of police officers, firefighters, health-care professionals, and the general
public. This approach may be the only means of halting the spread of this
devastating disease.

(2) The general assembly further declares that the purpose of this part 20 is
to create and develop a program that will:

(a) Heighten awareness and enhance knowledge and understanding of
hepatitis C by disseminating educational materials and information about services
and strategies for detection and treatment to patients and the general public;

(b) Promote public awareness and knowledge about the risk factors, the
value of early detection, and the options available for the treatment of hepatitis C;

(c) Utilize any available technical assistance from and any educational and
training resources and services that have been developed by organizations with
appropriate expertise and knowledge of hepatitis C;

(d) Design a model screening process to provide guidelines for health-care
professionals to use to prevent further transmission of the hepatitis C virus and
prevent onset of chronic liver disease caused by hepatitis C by detecting and
treating chronic hepatitis C virus infection;

(e) Evaluate existing hepatitis C support services in the community and
assess the need for improving the quality and accessibility of these services; and

(f) Provide easy access to clear, complete, and accurate hepatitis C and
patient referral services information.

(3) The general assembly further finds, determines, and declares that it is
the intent of the general assembly to provide funding for the hepatitis C program
created in this part 20 for the fiscal year beginning July 1, 1999, and to review the
effectiveness of and the necessity for the hepatitis C program in determining the
reasonableness and the amount of future funding, if any.